#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease


Authors: Connor A. Emdin;  Mary E. Haas;  Amit V. Khera;  Krishna Aragam;  Mark Chaffin;  Derek Klarin;  George Hindy;  Lan Jiang;  Wei-Qi Wei;  Qiping Feng;  Juha Karjalainen;  Aki Havulinna;  Tuomo Kiiskinen;  Alexander Bick;  Diego Ardissino;  James G. Wilson;  Heribert Schunkert;  Ruth McPherson;  Hugh Watkins;  Roberto Elosua;  Matthew J. Bown;  Nilesh J. Samani;  Usman Baber;  Jeanette Erdmann;  Namrata Gupta;  John Danesh;  Danish Saleheen;  Kyong-Mi Chang;  Marijana Vujkovic;  Ben Voight;  Scott Damrauer;  Julie Lynch;  David Kaplan;  Marina Serper;  Philip Tsao;  Million Veteran Program;  Josep Mercader;  Craig Hanis;  Mark Daly;  Joshua Denny;  Stacey Gabriel;  Sekar Kathiresan
Published in the journal: Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease. PLoS Genet 17(4): e1009503. doi:10.1371/journal.pgen.1009503
Category: Correction
doi: https://doi.org/10.1371/journal.pgen.1009503

In this article, the genetic variant PNPLA3 p.I148M is misreported in several sentences as PNPLA3 p.I48M. The variant TM6SF2 p.E167K is misreported in one sentence as TM6SF2 p.E40K.

In the Introduction, the third sentence of the second paragraph:

For example, PNPLA3 p.I48M and TM6SF2 p.E40K, although initially identified as associated with hepatic steatosis [9,10], strongly predispose to the development of alcoholic cirrhosis [11], non-alcoholic cirrhosis [12,13] and hepatitis C-related cirrhosis [14,15].

should read:

For example, PNPLA3 p.I1148M and TM6SF2 p.E167K, although initially identified as associated with hepatic steatosis [9,10], strongly predispose to the development of alcoholic cirrhosis [11], non-alcoholic cirrhosis [12,13] and hepatitis C-related cirrhosis [14,15].

In the Results, the fourth sentence of the first paragraph:

We examined the association of all-cause cirrhosis with six genetic variants previously reported to be associated with alcoholic or non-alcoholic cirrhosis: PNPLA3 I48M, TM6SF2 E167K, MBOAT7 rs641738, HSD17B13 rs72613567, HFE C282Y and SERPINA1 E366K [11,16,18,19].

should read:

We examined the association of all-cause cirrhosis with six genetic variants previously reported to be associated with alcoholic or non-alcoholic cirrhosis: PNPLA3 I148M, TM6SF2 E167K, MBOAT7 rs641738, HSD17B13 rs72613567, HFE C282Y and SERPINA1 E366K [11,16,18,19].

In the Methods, the first sentence of the first paragraph:

To examine whether known alcoholic and non-alcoholic cirrhosis variants associate with all-cause cirrhosis, we tested the association of six known cirrhosis variants (PNPLA3 I48M, TM6SF2 E167K, MBOAT7 rs641738, HSD17B13 rs72613567, HFE C282Y and SERPINA1 E366K [11,16,18,19]) with all-cause cirrhosis in UK Biobank (hospitalization or death due to ICD codes K70.2, K70.3, K70.4, K74.0, K74.1, K74.2, K74.6, K76.6, or I85).

should read:

To examine whether known alcoholic and non-alcoholic cirrhosis variants associate with all-cause cirrhosis, we tested the association of six known cirrhosis variants (PNPLA3 I148M, TM6SF2 E167K, MBOAT7 rs641738, HSD17B13 rs72613567, HFE C282Y and SERPINA1 E366K [11,16,18,19]) with all-cause cirrhosis in UK Biobank (hospitalization or death due to ICD codes K70.2, K70.3, K70.4, K74.0, K74.1, K74.2, K74.6, K76.6, or I85).

There is an error in Table 1. The name p.I48M appears instead of p.I148M.

Tab. 1. DNA sequence variants associated with all-cause cirrhosis in the discovery analysis.
DNA sequence variants associated with all-cause cirrhosis in the discovery analysis.

There is an error in the label of S1 Fig. The name p.I48M appears instead of p.I148M. The authors have provided a corrected version here.

Supporting information

S1 Fig [pdf]
Risk of alcoholic, non-alcoholic and hepatitis C cirrhosis associated with PNPLA3 I148M, TM6SF2 E167K and HSD17B13.


Zdroje

1. Emdin CA, Haas ME, Khera AV, Aragam K, Chaffin M, Klarin D, et al. (2020) A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease. PLoS Genet 16(4): e1008629. https://doi.org/10.1371/journal.pgen.1008629 32282858


Článek vyšel v časopise

PLOS Genetics


2021 Číslo 4
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Hypertenze a hypercholesterolémie – synergický efekt léčby
nový kurz
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Multidisciplinární zkušenosti u pacientů s diabetem
Autoři: Prof. MUDr. Martin Haluzík, DrSc., prof. MUDr. Vojtěch Melenovský, CSc., prof. MUDr. Vladimír Tesař, DrSc.

Úloha kombinovaných preparátů v léčbě arteriální hypertenze
Autoři: prof. MUDr. Martin Haluzík, DrSc.

Halitóza
Autoři: MUDr. Ladislav Korábek, CSc., MBA

Terapie roztroušené sklerózy v kostce
Autoři: MUDr. Dominika Šťastná, Ph.D.

Všechny kurzy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#